UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
APRIL 3, 2001
- ------------------
(Date of earliest event reported)


LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission          (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                   Number)


358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)

336-229-1127
- ------------
(Registrant's telephone number, including area code)




ITEM 9. Regulation FD Disclosure.

   Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that
Bradford T. Smith, executive vice president of public affairs, is
scheduled to speak at the Thomas Weisel Healthcare Conference in
San Francisco on April 3.  The presentation will be audio-webcast
live at 2:00 p.m. Pacific Standard Time/5:00 p.m. Eastern
Standard Time, with a rebroadcast available for 30 days, and may
be heard online at www.labcorp.com.  To comply with the
Securities and Exchange Commission's Regulation FD, the Company
is filing this report to update all investors on its outlook.

   At the conference, Mr. Smith will reiterate Company guidance
for 2001, as filed in an 8K on February 14, 2001.  Mr. Smith will
state, "We expect revenue growth of 10 percent to 11 percent,
with a bad debt rate of 9.7 percent of sales, EBITDA margins of
approximately 20.5 percent to 21 percent of sales, and EPS growth
of approximately 45 percent to 50 percent.

   The statements in this report which are not historical facts
or information may be forward-looking statements.  These forward-
looking statements involve risks and uncertainties that could
cause the outcome to be materially different.  Certain of these
risks and uncertainties are listed in the Laboratory Corporation
of America-registered trademark-Holdings 2000 Form 10-K and
subsequent filings.



SIGNATURES

Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                        (Registrant)

               By:/s/ BRADFORD T. SMITH
                  ----------------------------------
                      Bradford T. Smith
                      Executive Vice President,
                      General Counsel, Secretary
                      and Compliance Officer



Date: April 3, 2001